SCINAI IMMUNOTHERAPEUTICS LTD. Cash and Restricted Cash
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) had Cash and Restricted Cash of $1.81 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-04-01
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.81M.
- 2025-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.13M.
- 2024-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.10M.
- 2024-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.21M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2025-12-31 | $1.81M 20-F · filed 2026-04-01 |
| 2025-06-30 | $1.13M 6-K · filed 2025-09-02 |
| 2024-12-31 | $2.10M 20-F · filed 2026-04-01 |
| 2024-06-30 | $3.21M 6-K · filed 2025-09-02 |
| 2023-12-31 | $5.01M 20-F · filed 2026-04-01 |
| 2023-06-30 | $7.63M 6-K · filed 2024-09-09 |
| 2023-03-31 | $10.93M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $14.21M 20-F · filed 2026-04-01 |
| 2022-06-30 | $11.42M 6-K/A · filed 2023-08-18 |
| 2022-03-31 | $15.53M 10-Q · filed 2023-05-15 |
| 2021-12-31 | $17.52M 20-F · filed 2025-05-07 |
| 2020-12-31 | $3.08M 20-F · filed 2024-05-15 |